Dr. Tillis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
N2950 State Road 67
Lake Geneva, WI 53147Phone+1 262-245-0535Fax+1 262-245-2248
Education & Training
- University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Pulmonary Disease and Critical Care Medicine, 1990 - 1993
- University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineResidency, Internal Medicine, 1986 - 1989
- University of Illinois College of MedicineClass of 1986
Certifications & Licensure
- IL State Medical License 1993 - 2026
- SC State Medical License 2019 - 2025
- WI State Medical License 2023 - 2025
- TX State Medical License 1987 - 1994
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema Start of enrollment: 2009 Mar 01
- Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study Start of enrollment: 2012 Oct 01
- Blinded Safety & Efficacy Placebo Controlled Study of Icatibant for Angiotensin Converting Enzyme Inhibitor Induced Angioedema Start of enrollment: 2013 Dec 02
Publications & Presentations
PubMed
- 177 citationsEffect of Endobronchial Coils vs Usual Care on Exercise Tolerance in Patients With Severe Emphysema: The RENEW Randomized Clinical TrialFrank C. Sciurba, Gerard J. Criner, Charlie Strange, Pallav L. Shah, Gaetane Michaud
JAMA. 2016-05-24 - 171 citationsPhase 2 trial of eritoran tetrasodium (E5564), a toll-like receptor 4 antagonist, in patients with severe sepsis.Mark Tidswell, William Tillis, Steven P. LaRosa, Melvyn Lynn, AE Wittek
Critical Care Medicine. 2010-01-01 - 10 citationsAssociation between asthma/chronic obstructive pulmonary disease overlap syndrome and healthcare utilization among the US adult population.Minchul Kim, William Tillis, Preeti Patel, Rachael M Davis, Carl V. Asche
Current Medical Research and Opinion. 2019-01-24
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: